Search results
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders...
Simply Wall St. via Yahoo Finance· 8 hours agoKey Insights BioNTech will host its Annual General Meeting on 17th of May CEO Ugur Sahin's total...
BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Simply Wall St. via Yahoo Finance· 3 days agoInvestors in BioNTech SE (NASDAQ:BNTX) had a good week, as its shares rose 2.3% to close at US$90.88...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 5 days agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 2 weeks agoOn BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the...
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoBioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the...
TD Cowen Raises BioNTech (NASDAQ:BNTX) Price Target to $98.00
ETF DAILY NEWS· 2 days agoBioNTech (NASDAQ:BNTX – Free Report) had its price objective lifted by TD Cowen from $95.00 to $98.00 in a report published on Tuesday, Benzinga reports. The brokerage currently ...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 5 days agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
What's Going With BioNTech Stock On Monday?
Benzinga· 5 days agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
BioNTech shares hold rating, price target raised By Investing.com
Investing.com· 4 days agoTuesday, BioNTech SE (NASDAQ:BNTX) shares maintained their Hold rating, but with an updated price...
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 5 days agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...